456 related articles for article (PubMed ID: 33938795)
1. Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index.
Avouac J; Degrave R; Vergneault H; Combier A; Wanono S; Boisson M; Frantz C; Allanore Y
Clin Exp Rheumatol; 2022 Jan; 40(1):150-157. PubMed ID: 33938795
[TBL] [Abstract][Full Text] [Related]
2. Validation of the fibrosis-4 (FIB-4) index in the diagnosis of liver disease of rheumatoid arthritis patients treated with methotrexate.
Miyata M; Kuroda M; Unakami M; Tasaki K; Migita K; Ohira H
Mod Rheumatol; 2019 Nov; 29(6):936-942. PubMed ID: 30379089
[No Abstract] [Full Text] [Related]
3. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
[TBL] [Abstract][Full Text] [Related]
4. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.
Lee SW; Park HJ; Kim BK; Han KH; Lee SK; Kim SU; Park YB
Arthritis Res Ther; 2012 Oct; 14(5):R232. PubMed ID: 23107811
[TBL] [Abstract][Full Text] [Related]
7. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
Feuchtenberger M; Kraus L; Nigg A; Schulze-Koops H; Schäfer A
Rheumatol Int; 2021 Jun; 41(6):1079-1087. PubMed ID: 33608744
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis.
Bafna P; Sahoo RR; Hazarika K; Manoj M; Rungta S; Wakhlu A
Clin Rheumatol; 2021 Sep; 40(9):3605-3613. PubMed ID: 33686476
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study.
Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YB; Han KH; Lee SW
Mod Rheumatol; 2020 Jan; 30(1):70-77. PubMed ID: 30557057
[No Abstract] [Full Text] [Related]
12. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
Atallah E; Grove JI; Crooks C; Burden-Teh E; Abhishek A; Moreea S; Jordan KM; Ala A; Hutchinson D; Aspinall RJ; Murphy R; Aithal GP
J Hepatol; 2023 May; 78(5):989-997. PubMed ID: 36702175
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.
Tang KT; Hung WT; Chen YH; Lin CH; Chen DY
Sci Rep; 2016 Mar; 6():22387. PubMed ID: 26928373
[TBL] [Abstract][Full Text] [Related]
14. Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S; Jatuworapruk K
Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374233
[No Abstract] [Full Text] [Related]
15. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
Alves JA; Fialho SC; Morato EF; Castro GR; Zimmermann AF; Ribeiro GG; Neves FS; Pereira IA
Rev Bras Reumatol; 2011; 51(2):141-4. PubMed ID: 21584420
[TBL] [Abstract][Full Text] [Related]
16. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
17. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
Choi SR; Park JW; Lee EB; Park JK
Clin Rheumatol; 2021 Nov; 40(11):4493-4500. PubMed ID: 34115231
[TBL] [Abstract][Full Text] [Related]
18. Influence of methotrexate on gastrointestinal symptoms in patients with rheumatoid arthritis.
Asai S; Nagai K; Takahashi N; Watanabe T; Matsumoto T; Asai N; Sobue Y; Ishiguro N; Kojima T
Int J Rheum Dis; 2019 Feb; 22(2):207-213. PubMed ID: 30168274
[TBL] [Abstract][Full Text] [Related]
19. Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis.
Decarriere G; Barnetche T; Combe B; Gaujoux-Viala C; Lukas C; Morel J; Daien C
Arthritis Care Res (Hoboken); 2021 Jun; 73(6):873-884. PubMed ID: 32216091
[TBL] [Abstract][Full Text] [Related]
20. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.
Fleischmann R; Koenig AS; Szumski A; Nab HW; Marshall L; Bananis E
Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]